dalteparin has been researched along with Contusions in 4 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Contusions: Injuries resulting in hemorrhage, usually manifested in the skin.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We then randomly assigned them to receive daily 80 mg of aspirin plus open-label subcutaneous nadroparin (at a dose of 2850 IU, starting as soon as a viable pregnancy was demonstrated), 80 mg of aspirin alone, or placebo." | 5.14 | Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. ( Büller, HR; Folkeringa, N; Goddijn, M; Hamulyák, K; Hutten, BA; Kaandorp, SP; Middeldorp, S; Mol, BW; Nahuis, M; Papatsonis, DN; van der Post, JA; van der Veen, F; Verhoeve, HR, 2010) |
| "Enoxaparin dosing is currently based on total body weight." | 1.32 | Development of a dosing strategy for enoxaparin in obese patients. ( Duffull, SB; Green, B, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaandorp, SP | 1 |
| Goddijn, M | 1 |
| van der Post, JA | 1 |
| Hutten, BA | 1 |
| Verhoeve, HR | 1 |
| Hamulyák, K | 1 |
| Mol, BW | 1 |
| Folkeringa, N | 1 |
| Nahuis, M | 1 |
| Papatsonis, DN | 1 |
| Büller, HR | 1 |
| van der Veen, F | 1 |
| Middeldorp, S | 1 |
| Amaniyan, S | 1 |
| Varaei, S | 1 |
| Vaismoradi, M | 1 |
| Haghani, H | 1 |
| Sieloff, C | 1 |
| Green, B | 1 |
| Duffull, SB | 1 |
| Kuzu, N | 1 |
| Ucar, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effects of Aspirin and Intrauterine Balloon on the Post-operative Uterine Endometrial Repair and Reproductive Prognosis in Patients With Severe Intrauterine Adhesion: a Prospective Cohort Study[NCT02744716] | 114 participants (Actual) | Interventional | 2011-05-31 | Completed | |||
| Low-molecular-weight Heparin to Prevent Recurrent VTE in Pregnancy: a Randomized Controlled Trial of Two Doses[NCT01828697] | Phase 4 | 1,110 participants (Actual) | Interventional | 2013-04-24 | Completed | ||
| The Effect of Three Different Local Cold Applications on Pain and Ecchymosis in Subcutaneous Heparin Injections[NCT04235244] | 54 participants (Actual) | Interventional | 2020-06-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for dalteparin and Contusions
| Article | Year |
|---|---|
Aspirin plus heparin or aspirin alone in women with recurrent miscarriage.
Topics: Abortion, Habitual; Adult; Anticoagulants; Aspirin; Contusions; Drug Therapy, Combination; Female; H | 2010 |
Aspirin plus heparin or aspirin alone in women with recurrent miscarriage.
Topics: Abortion, Habitual; Adult; Anticoagulants; Aspirin; Contusions; Drug Therapy, Combination; Female; H | 2010 |
Aspirin plus heparin or aspirin alone in women with recurrent miscarriage.
Topics: Abortion, Habitual; Adult; Anticoagulants; Aspirin; Contusions; Drug Therapy, Combination; Female; H | 2010 |
Aspirin plus heparin or aspirin alone in women with recurrent miscarriage.
Topics: Abortion, Habitual; Adult; Anticoagulants; Aspirin; Contusions; Drug Therapy, Combination; Female; H | 2010 |
Effect of local cold and hot pack on the bruising of enoxaparin sodium injection site: a randomized controlled trial.
Topics: Cold Temperature; Contusions; Enoxaparin; Female; Hot Temperature; Humans; Injections, Subcutaneous; | 2016 |
The effect of cold on the occurrence of bruising, haematoma and pain at the injection site in subcutaneous low molecular weight heparin.
Topics: Anticoagulants; Clinical Nursing Research; Contusions; Cryotherapy; Enoxaparin; Female; Hematoma; Hu | 2001 |
1 other study available for dalteparin and Contusions
| Article | Year |
|---|---|
Development of a dosing strategy for enoxaparin in obese patients.
Topics: Anticoagulants; Contusions; Enoxaparin; Female; Fibrinolytic Agents; Humans; Logistic Models; Male; | 2003 |